Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...
WALTHAM, Mass. and BOULDER, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...
Flatiron Health today announced their planned presence at the International Society for Pharmacoeconomics and Outcomes Research Europe (ISPOR Europe) 2024 Annual Meeting, including five accepted ...
5d
Will present initial Phase 1C dose escalation data for vilastobart (XTX101), a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with ...
A poster campaign is creating awareness commemorating Edmonton-area soldiers who never came home. Joe MacDonald, the founder ...
Issuer: CureVac / Key word (s): Conference CureVac to Present at the 12th International mRNA Health Conference 04.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this ...
CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Present at the 12th Interna ...
"Our Q3 2024 Group revenue grew by +10.9%, +11.1% on an organic basis, above our expectations, to reach €948.2 million with a ...
BaboBot catches on at Babson. Now will businesses bite? The students behind BaboBot, a free instant messaging tool that ...
Donald Trump's 'racism is blatant' and ignores the reality of his own family history, lawyer claims 'I traveled over 300 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback